Skip to main content

High-Dimensional single cell mapping of inflammatory disease signatures in monozygotic twins

Objective

Multiple Sclerosis (MS) is a chronic inflammatory disease, where immune cell invasion into the central nervous system causes immunopathology and neurological deficit. Although disease-modifying therapies dramatically reduce disease activity, they hold the potential for severe adverse effects while long-term disability prospects remain poor. Moreover, there is to date no biomarker for monitoring the disease activity and to guide therapy decisions. I propose that the key to identifying such biomarkers is to combine single-cell mapping of leukocytes across well-curated patient cohorts with unbiased machine-learning based data interrogation. Using such an approach, we have already delineated a disease signature in a helper T cell population specific for MS. However, the immune compartment of cross-sectional cohorts is influenced by the individual genetic make up, which masks disease-specific signals and hinders a more precise characterisation of involved immune cell populations. To eliminate genetic influences, I here propose in aim 1 to interrogate the immune compartment of a unique cohort of monozygotic twin pairs -discordant for MS- and deeply analyse peripheral blood lymphocytes by single-cell mass cytometry, combined TcR and single cell sequencing, and epigenetic profiling. aim 2 to develop representation-learning methods to account for the paired genetics of twins or longitudinal samples and to include clinical covariates into the high-dimensional data set. aim 3 to use well-defined patient samples of MS-like disorders (MS-Mimics) and longitudinal samples of patients undergoing disease-modifying therapy (e.g. B cell depletion, autologous stem cell transplant) using single-cell mass cytometry. Ultimately, the goal is to reduce the dimensionality of disease signature(s) towards a clinically translatable low-dimensional biomarker that could be identified and quantified by routine methods available in the clinics.

Field of science

  • /medical and health sciences/basic medicine/neurology/multiple sclerosis

Call for proposal

ERC-2019-ADG
See other projects for this call

Funding Scheme

ERC-ADG - Advanced Grant

Host institution

UNIVERSITAT ZURICH
Address
Ramistrasse 71
8006 Zurich
Switzerland
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 2 492 221

Beneficiaries (1)

UNIVERSITAT ZURICH
Switzerland
EU contribution
€ 2 492 221
Address
Ramistrasse 71
8006 Zurich
Activity type
Higher or Secondary Education Establishments